1. ADAM10 inhibition improves survival and augments cardiac function after myocardial infarction. (25th November 2020) Authors: Klapproth, E; Kuenzel, S; Guenscht, M; Lorenz, K; Weber, S; Guan, K; El-Armouche, A Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PLK2 is a novel regulator of osteopontin-driven fibrosis and diastolic dysfunction in permanent atrial fibrillation. (25th November 2020) Authors: Kuenzel, S; Klapproth, E; Kuenzel, K; Piorkowski, C; Mayr, M; Wagner, M; Dobrev, D; Rausch, J.S.E; Ravens, U; Weber, S; El-Armouche, A Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗